IDEXX Laboratories Inc (IDXX)
494.04
+14.47
(+3.02%)
USD |
NASDAQ |
Apr 23, 16:00
493.95
-0.09
(-0.02%)
After-Hours: 20:00
IDEXX Laboratories Profit Margin (Quarterly): 21.58% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 21.58% |
| September 30, 2023 | 23.18% |
| June 30, 2023 | 23.76% |
| March 31, 2023 | 23.78% |
| December 31, 2022 | 20.78% |
| September 30, 2022 | 21.50% |
| June 30, 2022 | 15.34% |
| March 31, 2022 | 23.19% |
| December 31, 2021 | 20.32% |
| September 30, 2021 | 21.62% |
| June 30, 2021 | 24.52% |
| March 31, 2021 | 26.26% |
| December 31, 2020 | 24.24% |
| September 30, 2020 | 20.26% |
| June 30, 2020 | 23.36% |
| March 31, 2020 | 17.85% |
| December 31, 2019 | 14.95% |
| September 30, 2019 | 17.98% |
| June 30, 2019 | 20.27% |
| March 31, 2019 | 17.82% |
| December 31, 2018 | 15.59% |
| September 30, 2018 | 17.10% |
| June 30, 2018 | 18.72% |
| March 31, 2018 | 16.64% |
| December 31, 2017 | 7.56% |
| Date | Value |
|---|---|
| September 30, 2017 | 14.33% |
| June 30, 2017 | 16.77% |
| March 31, 2017 | 14.94% |
| December 31, 2016 | 11.82% |
| September 30, 2016 | 12.59% |
| June 30, 2016 | 14.40% |
| March 31, 2016 | 11.02% |
| December 31, 2015 | 11.10% |
| September 30, 2015 | 10.88% |
| June 30, 2015 | 13.77% |
| March 31, 2015 | 12.18% |
| December 31, 2014 | 7.38% |
| September 30, 2014 | 13.60% |
| June 30, 2014 | 14.67% |
| March 31, 2014 | 12.93% |
| December 31, 2013 | 12.22% |
| September 30, 2013 | 13.51% |
| June 30, 2013 | 15.31% |
| March 31, 2013 | 13.51% |
| December 31, 2012 | 13.57% |
| September 30, 2012 | 13.58% |
| June 30, 2012 | 15.29% |
| March 31, 2012 | 12.63% |
| December 31, 2011 | 12.37% |
| September 30, 2011 | 12.80% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
14.95%
Minimum
Dec 2019
26.26%
Maximum
Mar 2021
21.30%
Average
21.58%
Median
Dec 2023
Profit Margin (Quarterly) Benchmarks
| Stryker Corp | 19.66% |
| Haemonetics Corp | 9.29% |
| Align Technology Inc | 12.96% |
| Edwards Lifesciences Corp | 24.11% |
| ACADIA Pharmaceuticals Inc | 19.82% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 79.34% |
| Return on Assets | 28.60% |
| Return on Invested Capital | 38.84% |
| Gross Profit Margin (Quarterly) | 58.36% |
| Operating Margin (Quarterly) | 27.21% |
| Return on Net Operating Assets | 38.48% |